IT1149927B - Trans-5-aril-2, 3, 4, 4a, 5-9b-esaidro-1h-pirido (4.3-b) indoli sostituiti ad azione farmaceutica - Google Patents

Trans-5-aril-2, 3, 4, 4a, 5-9b-esaidro-1h-pirido (4.3-b) indoli sostituiti ad azione farmaceutica

Info

Publication number
IT1149927B
IT1149927B IT19373/80A IT1937380A IT1149927B IT 1149927 B IT1149927 B IT 1149927B IT 19373/80 A IT19373/80 A IT 19373/80A IT 1937380 A IT1937380 A IT 1937380A IT 1149927 B IT1149927 B IT 1149927B
Authority
IT
Italy
Prior art keywords
hexaidro
aril
pyrid
trans
pharmaceutical action
Prior art date
Application number
IT19373/80A
Other languages
English (en)
Other versions
IT8019373A0 (it
Inventor
Welch Willard Mckowan Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IT8019373A0 publication Critical patent/IT8019373A0/it
Application granted granted Critical
Publication of IT1149927B publication Critical patent/IT1149927B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
IT19373/80A 1979-01-23 1980-01-22 Trans-5-aril-2, 3, 4, 4a, 5-9b-esaidro-1h-pirido (4.3-b) indoli sostituiti ad azione farmaceutica IT1149927B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (2)

Publication Number Publication Date
IT8019373A0 IT8019373A0 (it) 1980-01-22
IT1149927B true IT1149927B (it) 1986-12-10

Family

ID=21717248

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19373/80A IT1149927B (it) 1979-01-23 1980-01-22 Trans-5-aril-2, 3, 4, 4a, 5-9b-esaidro-1h-pirido (4.3-b) indoli sostituiti ad azione farmaceutica

Country Status (34)

Country Link
US (1) US4224329A (it)
JP (4) JPS55100386A (it)
KR (1) KR830001932A (it)
AR (1) AR231291A1 (it)
AT (1) AT376674B (it)
AU (1) AU521986B2 (it)
BE (1) BE881283A (it)
CA (1) CA1144168A (it)
CH (2) CH651040A5 (it)
CS (4) CS221809B2 (it)
DD (2) DD149071A5 (it)
DE (1) DE3002367A1 (it)
DK (1) DK25580A (it)
EG (1) EG14767A (it)
FI (1) FI800179A (it)
FR (3) FR2447379A1 (it)
GB (1) GB2041925B (it)
GR (1) GR73567B (it)
HU (3) HU184712B (it)
IE (1) IE49500B1 (it)
IL (1) IL59189A (it)
IN (1) IN153300B (it)
IT (1) IT1149927B (it)
LU (1) LU82105A1 (it)
NL (1) NL8000385A (it)
NO (2) NO151895C (it)
NZ (3) NZ197582A (it)
PH (4) PH15736A (it)
PL (4) PL120774B1 (it)
PT (1) PT70724A (it)
SE (3) SE441358B (it)
SU (3) SU1168094A3 (it)
YU (2) YU269379A (it)
ZA (1) ZA796374B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (it) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
SE8404555L (sv) 1984-09-11
SE8404555D0 (sv) 1984-09-11
SE441358B (sv) 1985-09-30
DD149071A5 (de) 1981-06-24
ATA33380A (de) 1984-05-15
NZ197582A (en) 1984-05-31
BE881283A (fr) 1980-07-22
IL59189A0 (en) 1980-05-30
SU1168094A3 (ru) 1985-07-15
SE8404554L (sv) 1984-09-11
AU5476580A (en) 1980-07-31
AU521986B2 (en) 1982-05-13
CS221806B2 (en) 1983-04-29
LU82105A1 (fr) 1980-08-08
SE8404554D0 (sv) 1984-09-11
CS221807B2 (en) 1983-04-29
NO794317L (no) 1980-07-24
PL126867B1 (en) 1983-09-30
NZ192175A (en) 1984-05-31
NO843041L (no) 1980-07-24
JPS5636486A (en) 1981-04-09
IL59189A (en) 1984-01-31
JPS5636487A (en) 1981-04-09
YU242183A (en) 1984-06-30
JPS5636475A (en) 1981-04-09
PT70724A (en) 1980-02-01
CS221809B2 (en) 1983-04-29
NO151895C (no) 1985-06-26
EG14767A (en) 1985-12-31
ZA796374B (en) 1980-11-26
FI800179A (fi) 1980-07-24
IT8019373A0 (it) 1980-01-22
PH17773A (en) 1984-12-11
PL126532B1 (en) 1983-08-31
FR2447379B1 (it) 1983-08-19
FR2453174A1 (fr) 1980-10-31
CH651040A5 (fr) 1985-08-30
CA1144168A (en) 1983-04-05
PL120774B1 (en) 1982-03-31
SU1333239A3 (ru) 1987-08-23
JPS5855151B2 (ja) 1983-12-08
GR73567B (it) 1984-03-16
GB2041925B (en) 1982-10-20
SU1080746A3 (ru) 1984-03-15
CH648314A5 (fr) 1985-03-15
PH15736A (en) 1983-03-18
YU269379A (en) 1984-04-30
CS221808B2 (en) 1983-04-29
JPS5740151B2 (it) 1982-08-25
DK25580A (da) 1980-07-24
JPS55100386A (en) 1980-07-31
NZ197581A (en) 1984-05-31
IE800121L (en) 1980-07-23
HU189174B (en) 1986-06-30
FR2447379A1 (fr) 1980-08-22
NO151895B (no) 1985-03-18
PL126032B1 (en) 1983-07-30
HU184712B (en) 1984-10-29
SE8000329L (sv) 1980-07-24
PH15072A (en) 1982-06-03
DD156369A5 (de) 1982-08-18
GB2041925A (en) 1980-09-17
PL221248A1 (it) 1980-12-01
NL8000385A (nl) 1980-07-25
FR2453174B1 (it) 1983-07-29
DE3002367A1 (de) 1980-07-24
IN153300B (it) 1984-06-30
AR231291A1 (es) 1984-10-31
HU188201B (en) 1986-03-28
AT376674B (de) 1984-12-27
KR830001932A (ko) 1983-05-19
IE49500B1 (en) 1985-10-16
FR2453175A1 (fr) 1980-10-31
PH15086A (en) 1982-07-02
US4224329A (en) 1980-09-23
FR2453175B1 (it) 1983-07-29

Similar Documents

Publication Publication Date Title
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
IT8026836A0 (it) Transcodificatore.
IT1149927B (it) Trans-5-aril-2, 3, 4, 4a, 5-9b-esaidro-1h-pirido (4.3-b) indoli sostituiti ad azione farmaceutica
NO801060L (no) Elektrolyseapparat.
NO153847C (no) 2,4,4-triklor-4-formyl-butyronitril.
IT8025041A0 (it) Antibiotico u-59,761.
DK3881A (da) Substituerede 9,10-anthracen-bishydrazoner
FI73979B (fi) Framstaellning av och mellanprodukter till 2,6-dialkoxibensamider.
IT7922036A0 (it) 1,3-diaril-2-imino-imidazolidine e 2-imino-esaidro-pirimidine sostituite e procedimento per la loro preparazione.
NO803592L (no) 4,5-umettede prostansyre-derivater.
SE7803625L (sv) Trans-5-ary-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)indole
NL7920160A (nl) 24,24-difluor-25-hydroxycholecalciferol.
NL7803720A (nl) (1,5)pyrido2,3-bbenzothiazepine-derivaten.
NO800690L (no) Elektrolyseapparat.
NL7904089A (nl) Tetrahydrothiopyrano(2,3-b)indool-derivaten.
IT7823796A0 (it) 1,2,4-triazolidin-3-oni e-tioni.
IT7822883A0 (it) Procedimento per la preparazione di 3,5 di alogeno-aniline.
IT7829638A0 (it) 2,4-diammino-5-benzil-pirimidine eprocedimento per la loro preparazione.
IT1196913B (it) 6,7 secoergoline
NL7901111A (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen.
IT1140773B (it) Derivati della 1,17-bifenial-2-il alchilammina ad azione farmaceutica
SE8004517L (sv) Dubbelverkande, mekanisk sprutanordning for fluidum
FI881906A (fi) Saett och anordning foer renovering av en fraon en vaegg utskjutande, armerad betongplatta.
NL7803610A (nl) 2,4,6-trigesubstitueerde 2,3-dihydrobenzofuranen.
ES485474A0 (es) Procedimiento de obtencion del 4,4-(isopropilidenditio)-bis-(2,6-di-t-butilfenol)